CA2328291A1 - Substituted indolinones, the preparation thereof and their use as pharmaceutical compositions - Google Patents

Substituted indolinones, the preparation thereof and their use as pharmaceutical compositions Download PDF

Info

Publication number
CA2328291A1
CA2328291A1 CA002328291A CA2328291A CA2328291A1 CA 2328291 A1 CA2328291 A1 CA 2328291A1 CA 002328291 A CA002328291 A CA 002328291A CA 2328291 A CA2328291 A CA 2328291A CA 2328291 A1 CA2328291 A1 CA 2328291A1
Authority
CA
Canada
Prior art keywords
group
methyl
substituted
alkyl
methylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002328291A
Other languages
English (en)
French (fr)
Inventor
Armin Heckel
Rainer Walter
Wolfgang Grell
Jacobus C. A. Van Meel
Norbert Redemann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2328291A1 publication Critical patent/CA2328291A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA002328291A 1998-06-04 1999-05-28 Substituted indolinones, the preparation thereof and their use as pharmaceutical compositions Abandoned CA2328291A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19824922.5 1998-06-04
DE19824922A DE19824922A1 (de) 1998-06-04 1998-06-04 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
PCT/EP1999/003692 WO1999062882A1 (de) 1998-06-04 1999-05-28 Substituierte indolinone, ihre herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
CA2328291A1 true CA2328291A1 (en) 1999-12-09

Family

ID=7869856

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002328291A Abandoned CA2328291A1 (en) 1998-06-04 1999-05-28 Substituted indolinones, the preparation thereof and their use as pharmaceutical compositions

Country Status (23)

Country Link
EP (1) EP1100779A1 (bg)
JP (1) JP2002516906A (bg)
KR (1) KR20010043973A (bg)
CN (1) CN1303374A (bg)
AU (1) AU764782B2 (bg)
BG (1) BG104938A (bg)
BR (1) BR9910898A (bg)
CA (1) CA2328291A1 (bg)
CO (1) CO5050294A1 (bg)
DE (1) DE19824922A1 (bg)
EA (1) EA003514B1 (bg)
EE (1) EE200000723A (bg)
HR (1) HRP20000831A2 (bg)
HU (1) HUP0102210A3 (bg)
ID (1) ID27035A (bg)
IL (1) IL138702A0 (bg)
NO (1) NO20006138L (bg)
PL (1) PL344467A1 (bg)
SK (1) SK18222000A3 (bg)
TR (1) TR200003515T2 (bg)
WO (1) WO1999062882A1 (bg)
YU (1) YU73900A (bg)
ZA (1) ZA200005435B (bg)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858616B2 (en) 2002-07-23 2010-12-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6 position, their preparation and their use as medicaments
US10154990B2 (en) 2004-12-24 2018-12-18 Boehringer Ingelheim International Gmbh Medicaments for the treatment or prevention of fibrotic diseases

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19816624A1 (de) * 1998-04-15 1999-10-21 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
GB9904933D0 (en) 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
US6624171B1 (en) 1999-03-04 2003-09-23 Smithkline Beecham Corporation Substituted aza-oxindole derivatives
UA75054C2 (uk) * 1999-10-13 2006-03-15 Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу
US6762180B1 (en) 1999-10-13 2004-07-13 Boehringer Ingelheim Pharma Kg Substituted indolines which inhibit receptor tyrosine kinases
EP1339680A1 (en) * 2000-09-01 2003-09-03 Glaxo Group Limited Substituted oxindole derivatives as tyrosine kinase inhibitors
AU8664701A (en) * 2000-09-01 2002-03-22 Glaxo Group Ltd Oxindole derivatives
DE10117204A1 (de) * 2001-04-06 2002-10-10 Boehringer Ingelheim Pharma In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
DK1401415T3 (da) * 2001-06-29 2006-10-16 Ab Science Anvendelse af N-phenyl-2-pyrimidinamin-derivater til behandling af inflammatoriske sygdomme
JP2004537542A (ja) 2001-06-29 2004-12-16 アブ サイエンス 炎症性腸疾患（ｉｂｄ）を治療するための、チロシンキナーゼ阻害剤の使用
US7727731B2 (en) 2001-06-29 2010-06-01 Ab Science Potent, selective and non toxic c-kit inhibitors
CA2452371A1 (en) 2001-06-29 2003-01-09 Ab Science Use of tyrosine kinase inhibitors for treating allergic diseases
US20050176687A1 (en) * 2001-06-29 2005-08-11 Alain Moussy Use of tyrosine kinase inhibitors for treating autoimmune diseases
AU2002341881B2 (en) 2001-09-27 2008-05-08 Allergan, Inc. 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
JP4879492B2 (ja) * 2002-11-27 2012-02-22 アラーガン、インコーポレイテッド 疾患の治療のためのキナーゼ阻害剤
DE102004012070A1 (de) * 2004-03-12 2005-09-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue cycloalkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
SG177128A1 (en) * 2006-12-05 2012-01-30 Arena Pharm Inc Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
GB0706072D0 (en) * 2007-03-28 2007-05-09 Sterix Ltd Compound
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
CN101735071A (zh) * 2009-12-04 2010-06-16 大连凯飞精细化工有限公司 一种生产4-n,n-二甲胺基甲基苯胺的方法
CN103102352B (zh) * 2011-11-15 2015-08-12 山东亨利医药科技有限责任公司 酪氨酸激酶抑制剂吲哚满酮衍生物
CN103130775B (zh) * 2011-11-22 2015-09-30 山东亨利医药科技有限责任公司 作为酪氨酸激酶抑制剂的吲哚满酮衍生物
GB201208775D0 (en) 2012-05-18 2012-07-04 Uni I Oslo Chemical compounds
CN103848814B (zh) * 2012-12-06 2016-08-17 山东亨利医药科技有限责任公司 作为酪氨酸激酶抑制剂的取代吲哚满酮衍生物
EP3966207B1 (en) 2019-05-10 2023-11-01 Deciphera Pharmaceuticals, LLC Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof
US20240150368A1 (en) * 2022-09-02 2024-05-09 Deciphera Pharmaceuticals, Llc Ulk inhibitors and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE838623A (fr) * 1976-02-16 1976-06-16 Derives de 3-hydroxymethylene-2-indolinone et procede pour leur production
US4145422A (en) * 1977-09-06 1979-03-20 Abbott Laboratories Aminomethylene oxindoles
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
AU4155697A (en) * 1996-08-23 1998-03-06 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858616B2 (en) 2002-07-23 2010-12-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6 position, their preparation and their use as medicaments
US10154990B2 (en) 2004-12-24 2018-12-18 Boehringer Ingelheim International Gmbh Medicaments for the treatment or prevention of fibrotic diseases

Also Published As

Publication number Publication date
SK18222000A3 (sk) 2001-08-06
DE19824922A1 (de) 1999-12-09
JP2002516906A (ja) 2002-06-11
ZA200005435B (en) 2002-01-07
EP1100779A1 (de) 2001-05-23
CN1303374A (zh) 2001-07-11
ID27035A (id) 2001-02-22
IL138702A0 (en) 2001-10-31
EA200100001A1 (ru) 2001-08-27
AU764782B2 (en) 2003-08-28
TR200003515T2 (tr) 2001-06-21
CO5050294A1 (es) 2001-06-27
KR20010043973A (ko) 2001-05-25
HRP20000831A2 (en) 2001-12-31
YU73900A (sh) 2003-04-30
BR9910898A (pt) 2001-02-13
EA003514B1 (ru) 2003-06-26
NO20006138D0 (no) 2000-12-01
HUP0102210A2 (hu) 2001-11-28
WO1999062882A1 (de) 1999-12-09
PL344467A1 (en) 2001-11-05
EE200000723A (et) 2002-04-15
HUP0102210A3 (en) 2002-12-28
BG104938A (bg) 2001-06-29
NO20006138L (no) 2001-02-01
AU4370799A (en) 1999-12-20

Similar Documents

Publication Publication Date Title
CA2328291A1 (en) Substituted indolinones, the preparation thereof and their use as pharmaceutical compositions
CA2323111C (en) New substituted indolinones, the preparation thereof and their use as pharmaceutical compositions
AU763361B2 (en) Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/CDK complexes
US6762180B1 (en) Substituted indolines which inhibit receptor tyrosine kinases
EP1224170B1 (de) In 6-stellung substituierte indolinone, ihre herstellung und ihre verwendung als arzneimittel
EP1212318B1 (de) Substituierte indolinone als tyrosinkinase inhibitoren
US6169106B1 (en) Indolinones having kinase inhibitory activity
EP1224169A2 (de) In 5-stellung substituierte indolinone und ihre verwendung als kinase und cyclin/cdk-komplexe inhibitoren
WO2000073297A1 (de) Substituierte indolinone als tyrosinkinase inhibitoren
US6545035B1 (en) Substituted indolinones with kinase inhibitory activity
CZ20004520A3 (cs) Substituované indolinony, způsob jejich výroby a jejich použití
CZ20003788A3 (cs) Substituované indolinony
MXPA00010095A (en) Substituted indolinones, the production thereof and their use as medicaments

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued